|
ATOS Atossa Therapeutics Inc 1488039 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-8,491,000.00 |
| Balance Sheet |
|
Current Assets
|
$31,010,000.00 |
|
Assets
|
$32,281,000.00 |
|
Current Liabilities
|
$5,451,000.00 |
|
Liabilities
|
$5,451,000.00 |
|
Equity
|
$26,830,000.00 |
|
Shares Out
|
9979298.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-19,225,000.00 |
| Market Analysis |
Market Cap
|
$25,846,381.82 |
|
Price
|
$2.59 |
|
BVPS
|
2.69 |
|
PB
|
0.96 |
|
EPS
|
-0.95 |
|
FCF
|
$-19,225,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:58 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:48 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ATOS documents filed with the SEC.
ATOS Filings
Clear
